March 25, 2020
Coronavirus exposes the weak links in the pharma supply chainMadhav Durbha, LLamasoft group vice president of industry strategy, wrote an article for The Pharma Letter.
"While much is being written and said about the short-term supply chain challenges posed by the coronavirus outbreak, this ongoing outbreak is also bringing to the fore some systemic challenges in the pharma supply chain," Durbha writes. "The coronavirus' impact on the pharma industry is yet another reminder of the need to factor risk and resiliency into designing the supply networks."
-China as a strategic growth market for pharma companies, dominating supply
-The effects on the pharma industry
-Shortages of essential supplies
-The need to plan for launch for companies racing towards a vaccine
Read the full article (subscription required) here or download the PDF.